Zimbabwe has declined a significant US health deal valued at 367 million US dollars (272 million pounds) over five years because of Washington's insistence on confidential information.
This move became public following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesperson has since explained that the United States was seeking biological samples for research and commercial gain but was not willing to share the benefits from any future medical innovations.
"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged further dialogue to find a deal suitable to both sides so the country's critical HIV programme can be sustained.
Wider Implications
This development comes after a comparable case in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were raised about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.
As per reports, Sixteen nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our people should a new pandemic arise."
Sovereignty and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending structures already set up through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.
"This system is designed to ensure that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to ongoing discussions with our US partners on how subsequent co-operation might be designed in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
Medical experts expressed it recognised the official position, but suggested that negotiations need to persist considering much of the country's Aids initiatives depended on foreign aid.
"If technical issues exist, such as those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the continuing tensions between accepting vital international aid and protecting local interests in an increasingly interconnected world.